News Conference News ACC 2020 Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair L.A. McKeown April 07, 2020
News Conference News ACC 2020 Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS Todd Neale April 03, 2020
News Conference News ACC 2020 Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients L.A. McKeown April 01, 2020
News Conference News ACC 2020 PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery Yael L. Maxwell March 31, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Daily News More Support for DOAC-Based Double Therapy After PCI for A-fib Patients Todd Neale March 16, 2020
News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020
News Conference News ISC 2020 Optimal Time to Start Anticoagulation After Stroke Remains Unclear Todd Neale February 27, 2020
News Daily News No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients Todd Neale January 21, 2020
News Daily News Anticoagulation Prescription in the ED May Boost Later Use Todd Neale December 11, 2019
News Daily News Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights Shelley Wood December 02, 2019
News Daily News Long-term Watchman Data Reassure: CAP and CAP2 Registries Michael O'Riordan December 02, 2019
News Conference News AHA 2019 Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS Todd Neale November 20, 2019
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Daily News Dabigatran Discontinuation Rate Highest Early After Treatment Begins Todd Neale November 12, 2019
News Daily News Anticoagulant Type May Influence Fracture Risk in A-fib Patients Todd Neale October 21, 2019
News Daily News Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome Todd Neale October 15, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019